Navigation Links
Gene Network Sciences Names Departing Merck Head of Genetics Eric Schadt as Co-Chair of Scientific Advisory Board
Date:4/7/2009

CAMBRIDGE, Mass., April 7 /PRNewswire/ -- Gene Network Sciences, Inc. today announced that it named Dr. Eric Schadt, a leading researcher in the field of genomics-driven drug discovery, co-chair of its Scientific Advisory Board.

Dr. Schadt will be leaving his position as Executive Scientific Director of Genetics at pharmaceutical giant Merck to join forces with the departing head of Merck oncology, Dr. Stephen Friend, to create Sage, an open-access distributed data platform designed to enable collaboration by integrating the myriad of genomic data sets in the public and private domains. At Merck's Rosetta subsidiary, Dr. Schadt founded the Genetics department. His work at Merck focused on elucidating the genetic circuitry of common human diseases such as type 2 diabetes and obesity using novel integrative genomics approaches based on genetic and molecular profiling data. He has helped define a new field in network biology -- the genetics of gene expression, or "integrative genomics." Dr. Schadt's pioneering work in integrative genomics has been published in a series of groundbreaking papers, culminating in two seminal Nature papers in 2008 that revealed the genetic circuitry underlying obesity and metabolic disease.

Dr. Schadt is also an Affiliate Professor in the Department of Biostatistics at the University of Washington in Seattle, and he was recently appointed as a Fellow in the Institute of Synthetic and Systems Biology at Imperial College London. Prior to joining Rosetta, Dr. Schadt was a Senior Research Scientist at Roche Bioscience. He received his B.S. in applied mathematics/computer science from California Polytechnic State University, his M.A. in pure mathematics from UCD, and his Ph.D. in bio-mathematics from UCLA.

"I am looking forward to the opportunity to assist GNS in their efforts to accelerate the medical impact that is starting to be reaped from the emerging field of integrative genomics," said Dr. Schadt. "Among biosimulation companies, GNS's REFS(TM) platform is the best available technology to turn integrative genomics data into actionable knowledge for drug discovery and development."

Dr. Schadt will join renowned computational biologist Dr. James Collins of Boston University to serve together as co-chairs of GNS's Scientific Advisory Board.

"We are pleased to welcome the world's leading expert on the application of integrative genomics in pharmaceutical drug discovery," said Colin Hill, CEO of GNS. "The addition of Dr. Schadt to our Scientific Advisory Board exemplifies GNS's commitment to bring together the best scientific minds and technology to use supercomputer-driven modeling and simulation approaches to transform drug discovery and development and bring breakthrough treatments to patients in need."

About Gene Network Sciences

Gene Network Sciences (http://www.gnsbiotech.com/) is a leader in biosimulation with its ability to derive molecular mechanisms of drugs and diseases directly from molecular profiling and clinical data. Based in Cambridge, Massachusetts, and Ithaca, New York, GNS uses its REFS(TM) technology in pharmaceutical and healthcare settings to rapidly turn combinations of genetic, genomic, and clinical measurements into models of disease progression and drug response. These models are then simulated to discover both new targets for drug intervention and genetic markers of drug response that allow patients who will respond to a given drug treatment to be matched to a particular clinical trial and treatment option. By discovering how and why specific sets of genes and drug candidates impact human biology, GNS technology enables the rapid development of breakthrough drug and diagnostic products and the matching of patients to the optimal therapy.


'/>"/>
SOURCE Gene Network Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Medtronic Foundation Awards Fourth Grant to the National Parkinson Foundations National Parkinson Care Network Program
2. Companion Benefit Alternatives Awarded Silver Honors for Best Practices in Health Plans and Health Networks by URAC
3. Harris Corporation Awarded Follow-on Contract Option to Expand CONNECT Solution for Nationwide Health Information Network
4. Social Security Administration First to Go Live With CONNECT Solution for Nationwide Health Information Network
5. Harris Corporation Awarded $14 Million Contract to Develop Multi-Hospital Military Health System Network with Image-Sharing Capabilities
6. CONNECT Solution for Nationwide Health Information Network Released For General Availability by U.S. Government
7. UltraRAD and StructuRad Add Valor Network, Inc. to Client Roster
8. Interactive Autism Network opens its doors to adults with autism
9. Innovation and Sharing of Client Successes Highlight GetWellNetworks GetConnected2009 Conference
10. If You Treated an Illinois Workers Compensation Patient or a Patient Covered by an Illinois Automobile Insurance Policy and Your Bill was Reduced by a Discount Pursuant to a First Health or CCN PPO Network, Please Read This Notice Carefully As It Affects
11. Golub Capital Provides Debt Financing to Support the Acquisition of Network Express, Inc., by Ace Expediters, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based ... and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored ... 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 West Pharmaceutical ... innovative solutions for injectable drug administration, today announced that ... market opens on Thursday, October 26, 2017, and will ... and business expectations at 9:00 a.m. Eastern Time. To ... 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
Breaking Medicine Technology: